Conditions: Bipolar Depression
Keywords: Bipolar I, Depression
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 505
Healthy volunteers: no

Brief summary:
This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: lurasidone intervention 2: lurasidone intervention 3: Placebo
Intervention descriptions: intervention 1: lurasidone 20 mg/day for Days 1-2, 40 mg/day for Days 3-4, 60 mg/day for Days 5-6 and 80 mg/day on Day 7 and 80-120 mg/day intervention 2: lurasidone 20 mg/day for Days 1-7 intervention 3: Placebo Comparator

Protocol document: